文献速递外周动脉疾病

编辑推荐——比较覆膜支架与裸金属支架治疗髂总动脉的随机DISCOVER试验两年结果

Editor's Choice - Two Year Results of the Randomised DISCOVER Trial Comparing Covered Versus Bare Metal Stents in the Common Iliac Artery.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-11-03

这项多中心随机单盲对照优效性试验比较球囊扩张覆膜支架与裸金属支架治疗髂总动脉晚期动脉粥样硬化病变(狭窄长度>3 cm或闭塞),共纳入174条肢体(每组87条),随访两年。两组免于再狭窄率分别为84.7%与89.1%(p=.40),免于闭塞和免于靶病变血运重建等指标也均无显著差异。

要点

  • 髂总动脉晚期病变(狭窄>3 cm或闭塞)置入覆膜支架与裸金属支架,两年免于再狭窄率无显著差异。
  • 覆膜支架组两年免于再狭窄89.1%,裸金属支架组84.7%(p=.40)。
  • 两组技术成功、并发症、血流动力学成功和临床成功均相当。

核心结论

  • 对于髂总动脉晚期动脉粥样硬化病变,球囊扩张覆膜支架与裸金属支架治疗之间未发现差异。

研究设计与样本

  • 多中心、随机、单盲、对照优效性试验,比较球囊扩张覆膜支架与球囊扩张裸金属支架治疗髂总动脉晚期动脉粥样硬化病变(狭窄长度>3 cm或闭塞)。
  • 2012年至2019年间共纳入174条肢体,每组87条;裸金属支架组有6例患者交叉至覆膜支架组,但按意向性治疗原则分析。
  • 主要终点为随访两年后免于二分类再狭窄。

主要发现

  • 随访两年免于二分类再狭窄率:裸金属支架组84.7%(95%CI 76.7-92.7%),覆膜支架组89.1%(95%CI 82.4-95.8%),p=.40。
  • 免于闭塞率:裸金属支架组95.0%(95%CI 90.3-95.7%),覆膜支架组96.4%(95%CI 92.5-100%),p=.66。
  • 免于靶病变血运重建率:裸金属支架组91.1%(95%CI 84.8-97.3%),覆膜支架组95.2%(95%CI 90.7-99.7%),p=.31。
  • 两组技术成功、并发症、血流动力学成功和临床成功也相当;符合方案分析未影响研究结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It has been suggested that covered stents (CS) may lower restenosis rates compared with bare metal stents (BMS) after endovascular treatment of the common iliac artery. This trial aimed to provide additional evidence on the efficacy of CS vs. BMS in the common iliac artery. METHODS: This multicentre, randomised, single blind controlled superiority trial compared balloon expandable CS and balloon expandable BMS for advanced atherosclerotic lesions in the common iliac artery; this was defined as a stenosis > 3 cm in length or occlusion. The primary end point was freedom from binary restenosis after two years of follow up. The study was conducted according to the principles of the Declaration of Helsinki (version: October 2008) and registered with the Dutch Trial register (NTR3381). RESULTS: One hundred and seventy-four limbs were included between 2012 and 2019 with 87 limbs in each group. Six patients crossed over from the BMS group to the CS group but were analysed according to an intention to treat principle. Freedom from binary restenosis after two years of follow up was 84.7% (95% CI 76.7 - 92.7%) in the BMS group and 89.1% (95% CI 82.4 - 95.8%) in the CS group (p = .40). Freedom from occlusion was 95.0% (95% CI 90.3 - 95.7%) in the BMS group and 96.4% (95% CI 92.5 - 100%) in the CS group (p = .66). Freedom from target lesion revascularisation was 91.1% (95% CI 84.8 - 97.3%) and 95.2% (95% CI 90.7 -99.7%), respectively (p = .31). Technical success, complications, haemodynamic success, and clinical success were also comparable between both groups. Per-protocol analysis did not affect the outcomes of the study. CONCLUSION: No difference was found between balloon expandable CS and BMS for treating advanced atherosclerotic lesions of the common iliac artery.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bekken JA, Vroegindeweij D, Vos JA, et al. Editor's Choice - Two Year Results of the Randomised DISCOVER Trial Comparing Covered Versus Bare Metal Stents in the Common Iliac Artery. Eur J Vasc Endovasc Surg. 2022. PMID: 36336284. doi:10.1016/j.ejvs.2022.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。